Article Details

GSK's ViiV signs deal to develop longer-acting HIV drugs

Retrieved on: 2021-06-22 07:39:58

Tags for this article:

Click the tags to see associated articles and topics

GSK's ViiV signs deal to develop longer-acting HIV drugs. View article details on hiswai:

Excerpt

... and nucleoside reverse transcriptase translocation inhibitors (NRTTIs), capsid inhibitors and broadly neutralising monoclonal antibodies (bNAbs), ...

Article found on: www.sharecast.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up